Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma.
A 60-year-old man with multiple myeloma (MM) (IgG-kappa, stage IIIA) had been treated with minodronate at 6 mg orally as a phase 1 clinical trial for myeloma bone disease for 13 months (total dose, 4032 mg). Then he received incadronate at 10mg intravenously every 1 to 4 weeks (total dose, 350 mg). In July 2005, he complained of mild right mandibular pain, and bone scintigram showed a hot spot at the right side of the mandible. Panoramic radiograph showed osteonecrosis of the jaw (ONJ) and axial and 3-dimensional computed tomography confirmed ONJ. Oral examination showed massive gingival swelling of the right side of the mandible without exposed necrotic bone. He was given clarithromycin in addition to levofloxacin, followed by hyperbaric oxygen (HBO) therapy, which resulted in the complete disappearance of the pain. This is a first reported case of ONJ induced by incadronate. The present case suggests that early detection of ONJ by regular dental check-ups is important in the management of patients with MM who have received bisphosphonate therapy, and HBO in combination with antibiotic therapy is effective in the early stage of ONJ.
Shimura
Kazuho
K
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shimazaki
Chihiro
C
Taniguchi
Kyoko
K
Akamatsu
Sonoko
S
Okamoto
Masashi
M
Uchida
Ryo
R
Nomura
Ken-ichi
K
Inaba
Tohru
T
Horiike
Shigeo
S
Kanamura
Narisato
N
Taniwaki
Masafumi
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003952:Diagnostic Imaging / Q000379:methods; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006931:Hyperbaric Oxygenation; D007571:Jaw Diseases / Q000175:diagnosis; D008297:Male; D008334:Mandible / Q000473:pathology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*; D010146:Pain; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004164:Diphosphonates; C071542:cimadronate